Leslie N. Anderson

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN

Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton et al. · Clinical Cancer Research · 2016 · 126 citations

Medicine, Oncology, Pharmacology +17

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

Bruce Montgomery, Bevan Yueh, Michael Donahue et al. · Cancer · 2005 · 19 citations · Full text

Medicine, Oncology, Radiation Oncology +12

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

Laura Q.M. Chow, Rafael Santana-Dávila, Austin Pantel et al. · PLoS ONE · 2017 · 13 citations · Full text

Medicine, Nuclear Medicine, Oncology +17